NCAPG and central nervous system cancer: We found that NCAPG was significantly overexpressed in gliomas and that increased NCAPG expression correlated significantly with poor outcomes, tumor grade, age, IDH mutation status, and chromosome 1p/19q co-deletion status, as well as with the outcomes of radiotherapy and chemotherapy.